| Product Data |
| Applications |
Dot, WB |
| Recommend Dilution |
DB: 1:500, WB: 1:1000 |
| Reactivity |
Human, Mouse, Rat, Drosophila |
| Modifications |
Phospho-specific |
| Host |
Rabbit |
| Clonality |
Polyclonal |
| Immunogen |
This ERK1/2 Antibody is generated from rabbits immunized with a KLH conjugated synthetic phosphopeptide corresponding to amino acid residues surrounding T202/Y204 of human ERK1/2. |
| Isotype |
IgG |
| Formulation |
Purified polyclonal antibody supplied in PBS with 0.09% (W/V) sodium azide. |
| Concentration |
lot specific |
| Purification |
This antibody is purified through a protein A column, followed by peptide affinity purification. |
| Conjugation |
Unconjugated |
| Storage Condition |
Store at -20°C as received. |
| Predicted Protein Size |
43136 Da |
| Gene Name |
mitogen-activated protein kinase 3 |
| Database Link |
|
| Synonyms |
ERK-1; ERK1; ERT2; HS44KDAP; HUMKER1A; p44-ERK1; p44-MAPK; P44ERK1; P44MAPK; PRKM3 |
| Reference Data |
| Protein Families |
Druggable Genome, ES Cell Differentiation/IPS, Protein Kinase |
| Protein Pathways |
Acute myeloid leukemia, Adherens junction, Alzheimer's disease, Axon guidance, B cell receptor signaling pathway, Bladder cancer, Chemokine signaling pathway, Chronic myeloid leukemia, Colorectal cancer, Dorso-ventral axis formation, Endometrial cancer, ErbB signaling pathway, Fc epsilon RI signaling pathway, Fc gamma R-mediated phagocytosis, Focal adhesion, Gap junction, Glioma, GnRH signaling pathway, Insulin signaling pathway, Long-term depression, Long-term potentiation, MAPK signaling pathway, Melanogenesis, Melanoma, mTOR signaling pathway, Natural killer cell mediated cytotoxicity, Neurotrophin signaling pathway, NOD-like receptor signaling pathway, Non-small cell lung cancer, Oocyte meiosis, Pancreatic cancer, Pathways in cancer, Prion diseases, Progesterone-mediated oocyte maturation, Prostate cancer, Regulation of actin cytoskeleton, Renal cell carcinoma, T cell receptor signaling pathway, TGF-beta signaling pathway, Thyroid cancer, Toll-like receptor signaling pathway, Type II diabetes mellitus, Vascular smooth muscle contraction, VEGF signaling pathway |
